TNXP Financials
Tonix Pharmaceuticals Holding Corp - Financial statements & key metrics
Stock Price
$13.98
Market Cap
$194.48M
P/E Ratio
-0.1
EPS
$-176.60
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$10.09M
Gross Profit
-
Operating Income
-
Net Income
$-130.04M
EPS (Diluted)
$-176.60
Balance Sheet Highlights
Total Assets
$162.89M
Total Liabilities
$23.33M
Shareholders Equity
-
Cash & Equivalents
$98.78M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-60.92M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-1288.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is TNXP revenue?
TNXP's most recent quarterly revenue was $10.09M. Annual revenue can be calculated by summing the four most recent quarters.
Is TNXP profitable?
TNXP reported a loss of $130.04M in the most recent quarter. The net profit margin is -1288.3%.
What is TNXP market cap?
TNXP has a market capitalization of $194.48M, making it a small-cap stock.
Does TNXP have debt?
View TNXP's balance sheet for debt information.
What is TNXP cash flow?
Cash flow data is available in the full financial statements.